Patient and Patient Group Engagement in Cancer Clinical Trials: A Stakeholder Charter

Abstract

Background—to guide the implementation of patient centricity and engagement in cancer clinical trials (CTs) and to operationalize the Canadianized version of the Clinical Trials Transformation Initiative (C-CTTI) model, the development of a charter was identified by cancer CT stakeholders. Methods—the Canadian Cancer Trial Stakeholder Charter (the Charter) was initiated by Colorectal Cancer Canada (CCC) and developed via the—1—formation of an inclusive working group (WG) that drafted the document using recommendations collected during the development of the C-CTTI model; 2—socialization of the draft Charter to solicit feedback from cancer CT stakeholders, including those who attended the 2019 CCC Conference; and 3—incorporation of stakeholders’ feedback and finalization of the Charter by the WG. Results—the Charter was built around five guiding principles—1—patient centricity; 2—commitment to education and training; 3—collaboration as equal and independent partners in research; 4—transparency and accountability; and 5—high standards in data collection integrity and honesty. These principles led to the Charter’s five tenets, which stipulate stakeholder commitments, aiming to make CTs accessible to all patients, improve the design and implementation of CTs to benefit patients, expand recruitment and retention of patients in CTs, and further advance cancer research and treatment. Conclusions—the Charter is intended to integrate the patient voice into the Canadian cancer CT continuum. The next phases of the C-CTTI model include the adoption and implementation of the Charter, the establishment of a patient group training program, and the development of real-world evidence/real-world data methodologies.

Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision

“…Fourth, more effectively engaging patient advocates in trial design and effectively communicating with patients who are trial candidates about the drug under study, the trial design, biospecimen collection for biomarker development, and the potential benefit relative to the burden of trial participation is essential. 82 Optimizing patient education and engagement to enhance accrual rates, combined with efforts toward decentralization, have great potential to improve the efficiency of the clinical trial ecosystem and bring new advances to patients faster.…”

The Skin of Color Society’s Meeting the Challenge Summit, 2022

“…Given the complexity of the clinical trial ecosystem, progress toward equity will necessitate collaboration between numerous stakeholders, including federal agencies, industry, academic institutions, medical journals, participants, clinicians, investigators, and community-based organizations (Figure 2). 21 From a policy perspective,boldtop-downfederalinterventionsmustshiftcurrentparadigms.…”

“…Given the complexity of the clinical trial ecosystem, progress toward equity will necessitate collaboration between numerous stakeholders, including federal agencies, industry, academic institutions, medical journals, participants, clinicians, investigators, and community-based organizations (Figure 2). From a policy perspective, bold top-down federal interventions must shift current paradigms. In 2022, the US House of Representatives passed legislation requiring study sponsors to submit diversity action plans, including goals of enrollment and steps toward achieving goals for phase 3 studies of novel drugs .…”

Operationalizing Stakeholder Engagement Through the Stakeholder-Centric Engagement Charter (SCEC)

“…A charter can promote researcher-stakeholder partnerships that are authentic, inclusive, and sustainable by integrating best practices for engagement and including stakeholders in its development. 13,14 The Engagement Rubric developed by the Patient-Centered Outcomes Research Institute (PCORI) is one such stakeholder engagement framework. This Engagement Rubric introduces the Patient-Centered Outcomes Research Engagement Principles: reciprocal relationships, partnerships, co-learning, transparency-honesty-trust.…”